Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2025-12-25 @ 2:27 AM
NCT ID:
NCT06627634
Eligibility Criteria:
Inclusion Criteria:
* Age \> 18.
* Presence of primary T1-T4N0-N3M1 adenocarcinoma of the stomach or GEJ and max. 30% liver involvement.
* Primary tumour resectable, based on imaging workup.
* Surgical operable patients with ASA-score36 ≤ III and WHO performance status37 0-1.
* Patients eligible for treatment with systemic chemotherapy by FLOT regimen.
* Informed consent is obtained.
Exclusion Criteria:
* Patient with non-resectable cancer.
* Direct growth involving adjacent organs, i.e., pancreas, colon, blood vessels or bones.
* Other malignant disease diagnosed or treated up to 2 years prior to inclusion, except non-aggressive cancers such as non-melanoma sin cancer.
* Altered anatomy of the upper gastrointestinal tract due to previous surgery of the oesophagus, stomach, and duodenum.
* BMI ≤ 18
* The patient is unable to understand and/or read the consent form.
* Other serious illness or acute infections.
* Pregnant or breastfeeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06627634
Study Brief:
Protocol Section:
NCT06627634